Moreover, ROC curve analysis demonstrated potential of AKAP9 analysis in distinguishing FTC from PTC with 54.48 specificity and 100% sensitivity (AUC 0.848). This evidence concerns the gene AKAP9 and thyroid cancer, nonmedullary, 2.